JKT Equity Snapshot
DVLA Weekly Equity Report
PT Darya-Varia Laboratoria Tbk
What the company does
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Consumer Health Products, Prescription Drugs, Export & Toll Manufacturing, and Services. The company offers consumer health products, including skin nutrition products under the Natur-E brand; respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brands for nasal congestion, cough, and breathing issues caused by allergy; multivitamins under the Enervon-C, Enervon Active, Enervon Gold, and Supertin brands; vitamin C under the Vicee brand; supplement for kids with Zinc and vitamin C under the …
What the weekly tape is saying
DVLA closed the latest completed week at 1,530 IDR. The 4-week return is -4.4% and the 12-week return is -5.0%. Trend Signal is inactive, Market Dynamics is -1.42. Setup signature: Balanced read with a 56/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1,624 IDR
- Vs Trend Line
- -5.8%
- Fair Value
- 1,547 IDR
- Vs Fair Value
- -1.1%
- 52W High
- 1,695 IDR
- 52W Low
- 1,450 IDR
- Drawdown
- -9.7%
- Range Position
- 32.7%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 38
- 52W Active Breadth
- 73.1%
- Sector Scope
- ID Healthcare
- Sector Rank
- 28 of 37
- Sector Percentile
- 25.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
ID Healthcare
- Tracked Peers
- 37
- 4W Rank
- 10 of 37
- Avg 1W
- 3.8%
- Avg 4W
- -10.6%
- Trend Breadth
- 13.5%
- Positive MD
- 24.3%
ID Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 4
- 4W Rank
- 1 of 4
- Avg 1W
- 3.4%
- Avg 4W
- -19.5%
- Trend Breadth
- 25.0%
- Positive RS
- 75.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.42
- 4W MD Change
- -13.9%
- Relative Strength
- 20.37
- 4W RS Change
- 45.1%
- Expectation
- Negative
- Probability
- 40.86%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 132.6K
- 13W Average
- 83.4K
- 52W Average
- 195.1K
- Vs 13W
- 1.6x
- Vs 52W
- 0.7x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 1.6%
- 52W Volatility
- 1.7%
- Upside Weeks
- 19
- Downside Weeks
- 23
- Downside Breadth
- 44.2%
- Avg Gain / Loss
- 1.3% / -1.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- JKT
- Country
- ID
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- IDR
- Market Cap
- 1775.2B
Opportunity signals
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1,530 IDR | 2.0% | 1,624 IDR | 1,547 IDR | -1.42 | 20.37 | 132.6K | Off |
| 5 Jun 2026 | 1,500 IDR | -5.4% | 1,628 IDR | 1,547 IDR | -1.50 | 27.08 | 109.3K | Off |
| 29 May 2026 | 1,585 IDR | -0.3% | 1,634 IDR | 1,548 IDR | -1.35 | 23.11 | 36.3K | Off |
| 22 May 2026 | 1,590 IDR | -0.6% | 1,636 IDR | 1,548 IDR | -1.32 | 23.22 | 102.6K | Off |
| 15 May 2026 | 1,600 IDR | -0.6% | 1,638 IDR | 1,548 IDR | -1.25 | 14.04 | 67.3K | Off |
| 8 May 2026 | 1,610 IDR | 0.3% | 1,637 IDR | 1,548 IDR | -1.22 | 10.87 | 109.6K | Off |
| 1 May 2026 | 1,605 IDR | 0.3% | 1,636 IDR | 1,548 IDR | -1.30 | 10.78 | 31.9K | Off |
| 24 Apr 2026 | 1,600 IDR | -0.3% | 1,635 IDR | 1,548 IDR | -1.30 | 7.80 | 163.8K | Off |
| 17 Apr 2026 | 1,605 IDR | 0.3% | 1,635 IDR | 1,548 IDR | -1.41 | 1.07 | 60.1K | Off |
| 10 Apr 2026 | 1,600 IDR | 0.0% | 1,634 IDR | 1,549 IDR | -1.44 | 3.04 | 166.0K | Off |
| 3 Apr 2026 | 1,600 IDR | -0.3% | 1,633 IDR | 1,549 IDR | -1.52 | 9.39 | 49.0K | Off |
| 27 Mar 2026 | 1,605 IDR | -0.3% | 1,631 IDR | 1,549 IDR | -1.42 | 8.88 | 38.8K | Off |
| 20 Mar 2026 | 1,610 IDR | 0.0% | 1,632 IDR | 1,549 IDR | -1.22 | 9.23 | 17.3K | Off |
| 13 Mar 2026 | 1,610 IDR | -0.3% | 1,632 IDR | 1,549 IDR | -1.10 | 8.94 | 89.6K | Off |